Algeria

Africa

Contents

1. Regulatory Overview
2. Regulatory Pathways

Regulatory Overview

Algeria is regulated by the ANPP (Agence Nationale des Produits Pharmaceutiques). The country has 1 documented regulatory pathway for accessing unapproved or unlicensed medicines, covering named patient programs, compassionate use schemes, and special access arrangements.

Regulatory Authority

ANPP (Agence Nationale des Produits Pharmaceutiques)

Regulatory Pathways (1)

Algeria MOH Special Import Authorization 45 days

Algeria Ministry of Health special import authorization for unregistered medicines for patients with serious or life-threatening conditions.

Application Form: MOH Algeria Special Import Form

Legal Basis: Regulated

Eligibility: Serious or life-threatening condition with no locally registered alternative

Algeria

ISO Code	`DZ`
Region	Africa
Regulatory Authority	ANPP (Agence Nationale des Produits Pharmaceutiques)
Pathways	1 documented
Drugs Available	0 documented